Skip to main content
Premium Trial:

Request an Annual Quote

Eisai to Dissolve Dx R&D Subsidiary as It Focuses on Personalized Medicine

NEW YORK (GenomeWeb News) – Japanese drug firm Eisai and its diagnostics subsidiary Eidia said today that they are dissolving their diagnostics R&D subsidiary, Palma Bee'Z Research Institute, as part of the Eisai Group's transformation of its in vitro diagnostics development operations.

Palma Bee'Z will be dissolved effective March 31, 2013.

Palma Bee'Z will be absorbed into a new diagnostics research organization called the Diagnostics Development Department, formed in June with the merger of Eisai's Biomarker Personalized Medicine Core Function Unit (BPM CFU) with Eidia's diagnostics R&D operations. The Diagnostic Development Department was created in order to leverage advances in human biology to develop in vitro diagnostics, including companion diagnostics.

With the inclusion of Palma Bee'Z into the organization, Eisai said it "expects to further enhance its product creation structure, aiming to continue to realize early development of in vitro diagnostics." Additionally, it will "strengthen [Eisai Group's] product creation structure to reflect its focus on personalized medicine."

Palma Bee'Z was created in May 2002 in order to conduct R&D of diagnostics applying gene signal amplification technology developed by Eidia. As of March 31, 2012, it had ¥50 million ($638,816) in capital.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.